<DOC>
	<DOCNO>NCT00216385</DOCNO>
	<brief_summary>Tuberculosis currently treat 6-month course regimen . During time many patient might fail adhere treatment default , increase risk recurrent disease might multidrug resistant . A short duration treatment expect provide improve patient compliance least equal good clinical outcome . The aim trial evaluate efficacy safety gatifloxacin-containing regimen four month duration treatment pulmonary tuberculosis ,</brief_summary>
	<brief_title>A Controlled Trial 4-Month Quinolone-Containing Regimen Treatment Pulmonary Tuberculosis</brief_title>
	<detailed_description>In order evaluate efficacy safety 4-month test gatifloxacin-containing regimen , comparison make standard 6-month regimen , recommend WHO . Patients treat one two regimen randomly allocate . A total 2070 patient ne recruit trial followed-up duration 2 year . The trial multicentre , conduct 5 country Africa .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<criteria>Male female patient Aged 18 65 year Currently suffer recently diagnose microscopically proven pulmonary tuberculosis provide informed consent inclusion study . Patients history tuberculosis treatment within last 3 year History diabetes mellitus non insulin dependent diabetes mellitus require treatment Concomitant infection require additional antiinfective treatment ( especially antiretroviral therapy ) HIV infected patient WHO stage 3 infection except present `` loss weight &gt; 10 % body weight '' criterion HIV infect patient WHO stage 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>Treatment</keyword>
	<keyword>Quinolone</keyword>
	<keyword>Short course chemotherapy</keyword>
</DOC>